145 related articles for article (PubMed ID: 34119831)
21. Aldehyde oxidase; new approaches to old problems.
Beedham C
Xenobiotica; 2020 Jan; 50(1):34-50. PubMed ID: 31149862
[TBL] [Abstract][Full Text] [Related]
22. Aldehyde oxidase importance in vivo in xenobiotic metabolism: imidacloprid nitroreduction in mice.
Swenson TL; Casida JE
Toxicol Sci; 2013 May; 133(1):22-8. PubMed ID: 23462233
[TBL] [Abstract][Full Text] [Related]
23. Transfer learning enhanced graph neural network for aldehyde oxidase metabolism prediction and its experimental application.
Xiong J; Cui R; Li Z; Zhang W; Zhang R; Fu Z; Liu X; Li Z; Chen K; Zheng M
Acta Pharm Sin B; 2024 Feb; 14(2):623-634. PubMed ID: 38322350
[TBL] [Abstract][Full Text] [Related]
24. Nitroso-imidacloprid irreversibly inhibits rabbit aldehyde oxidase.
Dick RA; Kanne DB; Casida JE
Chem Res Toxicol; 2007 Dec; 20(12):1942-6. PubMed ID: 18001059
[TBL] [Abstract][Full Text] [Related]
25. Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay.
Cronin CN; Liu J; Grable N; Strelevitz TJ; Obach RS; Carlo A
Protein Expr Purif; 2021 Jan; 177():105749. PubMed ID: 32911062
[TBL] [Abstract][Full Text] [Related]
26. Structure-metabolism relationships in
Lepri S; Ceccarelli M; Milani N; Tortorella S; Cucco A; Valeri A; Goracci L; Brink A; Cruciani G
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3178-E3187. PubMed ID: 28373537
[TBL] [Abstract][Full Text] [Related]
27. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
Tan WK; Tan ARY; Sivanandam P; Goh EJH; Yap ZP; Saburulla NF; Austin-Muttitt K; Mullins JGL; Lau AJ
J Pharmacol Exp Ther; 2020 Aug; 374(2):295-307. PubMed ID: 32393528
[TBL] [Abstract][Full Text] [Related]
28. From Experiments to a Fast Easy-to-Use Computational Methodology to Predict Human Aldehyde Oxidase Selectivity and Metabolic Reactions.
Cruciani G; Milani N; Benedetti P; Lepri S; Cesarini L; Baroni M; Spyrakis F; Tortorella S; Mosconi E; Goracci L
J Med Chem; 2018 Jan; 61(1):360-371. PubMed ID: 29240409
[TBL] [Abstract][Full Text] [Related]
29. Identification of aldehyde oxidase as the neonicotinoid nitroreductase.
Dick RA; Kanne DB; Casida JE
Chem Res Toxicol; 2005 Feb; 18(2):317-23. PubMed ID: 15720138
[TBL] [Abstract][Full Text] [Related]
30. Contribution of Extrahepatic Aldehyde Oxidase Activity to Human Clearance.
Kozminski KD; Selimkhanov J; Heyward S; Zientek MA
Drug Metab Dispos; 2021 Sep; 49(9):743-749. PubMed ID: 34162687
[TBL] [Abstract][Full Text] [Related]
31. The role of aldehyde oxidase in drug metabolism.
Garattini E; Terao M
Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):487-503. PubMed ID: 22335465
[TBL] [Abstract][Full Text] [Related]
32. Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: in vitro and pharmacoepidemiological approaches.
Moriyama A; Ueda H; Narumi K; Asano S; Furugen A; Saito Y; Kobayashi M
Expert Opin Drug Metab Toxicol; 2024 May; 20(5):399-406. PubMed ID: 38706380
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde oxidase and its role as a drug metabolizing enzyme.
Dalvie D; Di L
Pharmacol Ther; 2019 Sep; 201():137-180. PubMed ID: 31128989
[TBL] [Abstract][Full Text] [Related]
34. Structure and function of mammalian aldehyde oxidases.
Terao M; Romão MJ; Leimkühler S; Bolis M; Fratelli M; Coelho C; Santos-Silva T; Garattini E
Arch Toxicol; 2016 Apr; 90(4):753-80. PubMed ID: 26920149
[TBL] [Abstract][Full Text] [Related]
35. Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy.
Sanoh S; Tayama Y; Sugihara K; Kitamura S; Ohta S
Drug Metab Pharmacokinet; 2015 Feb; 30(1):52-63. PubMed ID: 25760530
[TBL] [Abstract][Full Text] [Related]
36. Non-cytochrome P450 enzyme aldehyde oxidase is involved in the oxidative metabolic pathway of diquat and its detoxification effect.
Mao Z; Yu Y; Ba G; Zhao H; Shi Q; Cao Y; Xie W; Zhang J; Sun H; Chen F
Pestic Biochem Physiol; 2024 Feb; 199():105805. PubMed ID: 38458670
[TBL] [Abstract][Full Text] [Related]
37. Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development.
Gajula SNR; Nathani TN; Patil RM; Talari S; Sonti R
Drug Metab Rev; 2022 Nov; 54(4):427-448. PubMed ID: 36369949
[TBL] [Abstract][Full Text] [Related]
38. Effect of commonly used organic solvents on aldehyde oxidase-mediated vanillin, phthalazine and methotrexate oxidation in human, rat and mouse liver subcellular fractions.
Behera D; Pattem R; Gudi G
Xenobiotica; 2014 Aug; 44(8):722-33. PubMed ID: 24533630
[TBL] [Abstract][Full Text] [Related]
39. Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde Oxidase.
Paragas EM; Choughule K; Jones JP; Barr JT
Methods Mol Biol; 2021; 2342():257-284. PubMed ID: 34272698
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human aldehyde oxidase activity by diet-derived constituents: structural influence, enzyme-ligand interactions, and clinical relevance.
Barr JT; Jones JP; Oberlies NH; Paine MF
Drug Metab Dispos; 2015 Jan; 43(1):34-41. PubMed ID: 25326286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
